Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Methylene blue for intractable pain from oral mucositis related to cancer treatment: a randomized phase 2 clinical trial

Fig. 3

Mean pain numeric rating scale score reductions from baseline to day 2 by treatment arm. Mean pain numeric rating scale scores before and after treatment are shown for patients who received conventional therapy alone and those who received conventional therapy plus methylene blue (MB) oral rinse at three different concentrations. Lines indicate 95% confidence intervals of the mean

Back to article page